申请人:Takeda Pharmaceutical Company Limited
公开号:EP1553074A1
公开(公告)日:2005-07-13
The present invention provides a compound represented by the general formula:
[wherein Ring A represents an optionally substituted 5- to 8-membered ring, Ring B represents a further optionally substituted 4- to 10-membered ring, Ring C represents a further optionally substituted benzene ring, X1 represents carbon atom, X2 represents a carbon atom, an oxygen atom, etc., W represents a nitrogen atom, etc., Y11 represents a group represented by the formula CR2R3' (wherein R2 represents a hydrogen atom, a cyano group, a nitro group, etc., and R3' represents a hydrogen atom, a cyano group, a nitro group, etc., respectively), Y21 represents a group represented by the formula CR4R5' (wherein R4 represents a hydrogen atom, a cyano group, a nitro group, etc., and R5' represents a hydrogen atom, a cyano group, a nitro group, etc., respectively), etc., and R1 represents an electron-withdrawing group, respectively. The formula represents a single bond or a double bond] or a salt thereof, which is useful as an androgen receptor modulator.
本发明提供了通式所代表的化合物:
[其中环A代表任选取代的5-至8元环,环B代表进一步任选取代的4-至10元环,环C代表进一步任选取代的苯环,X1代表碳原子,X2代表碳原子、氧原子等,W代表氮原子等,Y11代表由式CR2R3'代表的基团(其中R2分别代表氢原子、
氰基、硝基等),Y21代表由式CR4R5'代表的基团、和 R3' 分别代表氢原子、
氰基、硝基等),Y21 代表式 CR4R5' 所代表的基团(其中 R4 代表氢原子、
氰基、硝基等,R5' 分别代表氢原子、
氰基、硝基等)等,R1 分别代表一个抽电子基团。式中代表单键或双键]或其盐,可用作雄激素受体调节剂。